Trial Profile
The Effectiveness of Eldecalcitol in the Osteoporotic Patients Who Are Bisphosphonate Non-responders After Long-term Bisphosphonate Treatment
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Pharmacodynamics
- 20 Sep 2021 Planned primary completion date changed from 1 Jan 2015 to 1 Dec 2022.
- 10 Aug 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2024.
- 19 May 2015 Status changed from not yet recruiting to recruiting, according to to ClinicalTrials.gov record.